Clinical Trial Update: A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer

View source ↗

Summary

This entry describes a real-world clinical trial of Inavolisib for HR-positive/HER2-negative, PIK3CA-mutated advanced breast cancer, with recruitment not yet st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inavolisib (Inavolisib)

Snippet

Sponsor: xuliang | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING